Pharmaceutical

We represent individuals injured by hazardous pharmaceutical products. And we have been repeatedly selected by courts to leadership roles in precedent-setting, national pharmaceutical litigation. Our work has helped thousands of individuals harmed by dangerous pharmaceutical products obtain billions of dollars in relief.

Representative Cases

• We served as plaintiffs’ liaison counsel in multi-district litigation involving the Yaz and Yasmin hormonal contraceptives that resulted in a settlement of nearly $2 billion. In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL 2100)
• We served as co-lead counsel in the Pradaxa multi-district litigation that resulted in a $650 million nationwide settlement. In re: Pradaxa (Dabigatran) Products Liability Litigation (MDL 2385)
• We served as lead counsel and lead negotiator in the NuvaRing litigation that resulted in a $100 million global settlement. In re: NuvaRing Products Liability Litigation (MDL 1964)